P014 Skin of Color Primer
DESCRIPTION
This session will provide a comprehensive and concise high-yield overview of common conditions seen in skin of color. Skin, hair, and nail conditions which either uniquely affect skin of color populations or which present differently in skin of color will be discussed. This will include inflammatory, neoplastic, pigmentary, and alopecic conditions and other high-yield common skin of color conditions. Discussion will include updates in pathogenesis, along with evaluation and management considerations. Complementary and alternative treatment approaches will also be discussed. Presentations will include unique cultural considerations and cultural competency in the delivery of care to diverse populations.
LEARNING OBJECTIVES
Improve diagnosing of dermatologic conditions in skin of color.
Select safe and effective treatment options for various conditions across diverse populations.
Identify cultural competency considerations in taking care of patients of color.
DIRECTOR
Nada Elbuluk, MD, FAAD
University of Southern California
SPEAKERS
Tina Bhutani, MD, FAAD
Cheryl M. Burgess, MD, FAAD
Pearl E. Grimes, MD, FAAD
The Vitiligo & Pigmentation Institute of Southern California
Amy J. McMichael, MD, FAAD
Wake Forest University School of Medicine
Rebecca Vasquez, MD
DISCLOSURES
Tina Bhutani, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Amgen – Investigator(Grants/Research Funding), Speaker(Honoraria); Apogee BioPharm – Advisory Board(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Arcutis, Inc. – Advisory Board(Fees); ASLAN Pharmaceuticals – Data Safety Monitoring Board(Fees), Data Safety Monitoring Board(Honoraria); Boehringer Ingelheim – Advisory Board(Fees); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Fees); Castle Biosciences – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Clementia Pharmaceuticals – Investigator(Grants/Research Funding); CoreEvitas, LLC – Investigator(Grants/Research Funding); Dermatology Foundation – Speaker(Honoraria); Dermavant Sciences – Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Fees); FIDE – Consultant(Fees); Galderma – Advisory Board(Honoraria), Speaker(Honoraria); Happify – Consultant(Fees); Incyte – Advisory Board(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Fees); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); LearnSkin – Speaker(Honoraria); Leo Pharma – Speaker(Honoraria); LEO Pharma, US – Advisory Board(Fees); Mindera – Investigator(Grants/Research Funding), Speaker(Honoraria); National Psoriasis Foundation – Speaker(Honoraria); Novartis – Advisory Board(Fees), Investigator(Grants/Research Funding); Ortho Dermatologics – Speaker(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Sanofi – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Taxa – Consultant (1099 relationship)(Stock); UCB – Advisory Board(Fees), Speaker(Honoraria);
Cheryl M. Burgess, MD, FAAD
Aerolase – Investigator(Equipment); Allergan, Inc. – Investigator(Grants/Research Funding), Stockholder(Stock); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Prollenium – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Target Cool – Advisory Board(Equipment); TEOXANE Laboratories – Investigator(Grants/Research Funding);
Nada Elbuluk, MD, FAAD
AbbVie – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Beiersdorf – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Canfield Scientific, Inc. – Consultant (1099 relationship)(Fees); Dior – Advisory Board(Fees); Eli Lilly and Company – Advisory Board(Fees), Investigator(Grants/Research Funding); Global Vitiligo Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Consultant(Fees); Janssen Biotech – Advisory Board(Fees), Consultant (1099 relationship)(Fees); Kao USA – Consultant (1099 relationship)(Fees); Kenvue – Advisory Board(Fees); L'Oreal USA Inc. – Advisory Board(Fees); McGraw-Hill Companies – Advisory Board(Fees), Other(Other Financial Benefit); Pfizer Inc. – Advisory Board(Fees), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees); SkinCeuticals LLC – Consultant (1099 relationship)(Fees); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); Teva Pharmaceuticals USA – Consultant (1099 relationship)(Fees); The Skin of Color Society – Board of Directors(No Compensation Received); VeraDermics Inc. – Consultant (1099 relationship)(Fees); VisualDx – Consultant(Stock Options); Women's Dermatologic Society – Board of Directors(No Compensation Received);
Pearl E. Grimes, MD, FAAD
AbbVie – Consultant(Honoraria); Incyte Corporation – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Grants/Research Funding); Laseroptek USA – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant(Honoraria); Scientis – Consultant (1099 relationship)(Honoraria); SkinBetter Science – Investigator(Grants/Research Funding); Versicolor Technologies – Consultant (1099 relationship)(Honoraria), Stockholder Private Company(Honoraria);
Amy J. McMichael, MD, FAAD
Aclaris Therapeutics Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Allergan, Inc. – Consultant(Honoraria); Apogee BioPharm – Advisory Board(No Compensation Received); Arcutis Biotherapeutics – Advisory Board(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Canfield Scientific, Inc. – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); CeraVe/Valeante – Consultant(Honoraria); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights); Galderma Laboratories, L.P. – Consultant(Other Financial Benefit); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Informa – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Johnson & Johnson Consumer Products Company – Consultant(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); L'Oreal USA Inc. – Advisory Board(Honoraria); LearnHealth/LearnSkin – Speaker/Faculty Education(Honoraria); Leo Pharma – Consultant (1099 relationship)(Honoraria); McGraw-Hill Companies – Other(Patent royalties or other compensation for Intellectual Property Rights); NAAF – Advisory Board(No Compensation Received); North American Hair Research Society – Board of Directors(No Compensation Received); Nutrafol – Advisory Board(Honoraria); Pelage Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant(Honoraria), Consultant(Other Financial Benefit); Procter & Gamble Company – Consultant(Honoraria), Investigator(Other Financial Benefit); Revian LTD. – Board of Directors(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); UCB – Consultant(Honoraria); UpToDate, Inc – Speaker/Faculty Education(Honoraria); VeraDermics Inc. – Consultant (1099 relationship)(Honoraria);
Rebecca Vasquez, MD
Incyte – Consultant (1099 relationship)(Honoraria);